Jason Drew Smith
General Counsel at UroGen Pharma · 12 reported transactions in 1 company · latest trade Sep 8, 2026
Their trades
Sold | Sep 8, 2026 | Sep 8, 2026 close $43.81 → Oct 29, 2026 close $33.48. S&P 500 +0.8% over the same days. | ||
Sold | Feb 3, 2026 | Feb 3, 2026 close $20.00 → Oct 29, 2026 close $33.48. S&P 500 +12.0% over the same days. | ||
Sold | Feb 3, 2026 | Feb 3, 2026 close $20.00 → Oct 29, 2026 close $33.48. S&P 500 +12.0% over the same days. | ||
Sold | Feb 3, 2026 | Feb 3, 2026 close $20.00 → Oct 29, 2026 close $33.48. S&P 500 +12.0% over the same days. | ||
Sold | Sep 8, 2025 | Sep 8, 2025 close $21.42 → Oct 29, 2026 close $33.48. S&P 500 +19.0% over the same days. |
SoldUroGen Pharma
$64.6K
Sep 8, 2026 close $43.81 → Oct 29, 2026 close $33.48. S&P 500 +0.8% over the same days.
SoldUroGen Pharma
$63.3K
Feb 3, 2026 close $20.00 → Oct 29, 2026 close $33.48. S&P 500 +12.0% over the same days.
SoldUroGen Pharma
$31.7K
Feb 3, 2026 close $20.00 → Oct 29, 2026 close $33.48. S&P 500 +12.0% over the same days.
SoldUroGen Pharma
$52.3K
Feb 3, 2026 close $20.00 → Oct 29, 2026 close $33.48. S&P 500 +12.0% over the same days.
SoldUroGen Pharma
$29K
Sep 8, 2025 close $21.42 → Oct 29, 2026 close $33.48. S&P 500 +19.0% over the same days.